CA3162615C - Film-coated tablets having smooth surface - Google Patents
Film-coated tablets having smooth surface Download PDFInfo
- Publication number
- CA3162615C CA3162615C CA3162615A CA3162615A CA3162615C CA 3162615 C CA3162615 C CA 3162615C CA 3162615 A CA3162615 A CA 3162615A CA 3162615 A CA3162615 A CA 3162615A CA 3162615 C CA3162615 C CA 3162615C
- Authority
- CA
- Canada
- Prior art keywords
- rpm
- jer
- film
- quadro
- smooth surface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019231824 | 2019-12-23 | ||
| JP2019-231824 | 2019-12-23 | ||
| PCT/JP2020/047412 WO2021132072A1 (ja) | 2019-12-23 | 2020-12-18 | 滑らかな表面を有するフィルムコーティング錠 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3162615A1 CA3162615A1 (en) | 2021-07-01 |
| CA3162615C true CA3162615C (en) | 2024-01-16 |
Family
ID=76574586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3162615A Active CA3162615C (en) | 2019-12-23 | 2020-12-18 | Film-coated tablets having smooth surface |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230081350A1 (https=) |
| EP (1) | EP4082536B1 (https=) |
| JP (1) | JP6993765B2 (https=) |
| KR (1) | KR20220119025A (https=) |
| CN (1) | CN114786653B (https=) |
| BR (1) | BR112022012382A2 (https=) |
| CA (1) | CA3162615C (https=) |
| ES (1) | ES3025936T3 (https=) |
| TW (1) | TWI820372B (https=) |
| WO (1) | WO2021132072A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2024248079A1 (https=) * | 2023-06-02 | 2024-12-05 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5883616A (ja) * | 1981-11-12 | 1983-05-19 | Asahi Kogyo Kk | 塩分補給用錠剤の製造方法 |
| US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
| WO2011081118A1 (ja) * | 2009-12-29 | 2011-07-07 | 興和株式会社 | 経口投与用医薬組成物 |
| CN104334169B (zh) | 2013-04-04 | 2016-11-02 | 第一三共株式会社 | 包含氨基羧酸盐的固体组合物 |
| JP6349306B2 (ja) * | 2013-04-25 | 2018-06-27 | 杏林製薬株式会社 | 錠剤 |
| BR112017019918B1 (pt) | 2015-03-19 | 2023-11-07 | Daiichi Sankyo Company, Limited | Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica |
| BR112017019920B1 (pt) | 2015-03-19 | 2023-11-07 | Daiichi Sankyo Company, Limited | Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica |
| BR112021001008A2 (pt) * | 2018-07-30 | 2021-04-20 | Daiichi Sankyo Company, Limited | comprimido de fármaco |
| US20200246317A1 (en) * | 2019-02-01 | 2020-08-06 | Cersci Therapeutics, Inc. | Methods of treating diabetic neuropathy with a thiazoline anti-hyperalgesic agent |
| CN110538153B (zh) * | 2019-09-26 | 2022-04-26 | 扬子江药业集团四川海蓉药业有限公司 | 一种高稳定性、快速释放的固体制剂及其制备方法 |
-
2020
- 2020-12-18 ES ES20904953T patent/ES3025936T3/es active Active
- 2020-12-18 EP EP20904953.5A patent/EP4082536B1/en active Active
- 2020-12-18 CN CN202080089589.0A patent/CN114786653B/zh active Active
- 2020-12-18 US US17/787,760 patent/US20230081350A1/en active Pending
- 2020-12-18 BR BR112022012382A patent/BR112022012382A2/pt unknown
- 2020-12-18 JP JP2021565706A patent/JP6993765B2/ja active Active
- 2020-12-18 WO PCT/JP2020/047412 patent/WO2021132072A1/ja not_active Ceased
- 2020-12-18 KR KR1020227020412A patent/KR20220119025A/ko active Pending
- 2020-12-18 CA CA3162615A patent/CA3162615C/en active Active
- 2020-12-21 TW TW109145257A patent/TWI820372B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2021132072A1 (https=) | 2021-07-01 |
| JP6993765B2 (ja) | 2022-02-07 |
| TWI820372B (zh) | 2023-11-01 |
| TW202135793A (zh) | 2021-10-01 |
| ES3025936T3 (en) | 2025-06-10 |
| WO2021132072A1 (ja) | 2021-07-01 |
| CN114786653A (zh) | 2022-07-22 |
| CN114786653B (zh) | 2023-10-31 |
| EP4082536B1 (en) | 2025-04-09 |
| BR112022012382A2 (pt) | 2022-08-30 |
| EP4082536A1 (en) | 2022-11-02 |
| US20230081350A1 (en) | 2023-03-16 |
| EP4082536A4 (en) | 2024-01-24 |
| KR20220119025A (ko) | 2022-08-26 |
| CA3162615A1 (en) | 2021-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3162615C (en) | Film-coated tablets having smooth surface | |
| CA3212313C (en) | Solid forms of treprostinil | |
| KR102417830B1 (ko) | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염 | |
| US20180155300A1 (en) | Solid state forms of trisodium valsartan: sacubitril | |
| PL165803B1 (pl) | Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL | |
| DE2744135A1 (de) | Cephalosporinderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| US20160145286A1 (en) | Novel Crystalline Hydrates of 1-(Beta-D-Glucopyranosyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2-Thienylmethyl]Benzene | |
| US20180354916A1 (en) | Preparation method for eutectic hydrate crystal form ii of ahu-377 and diovan trisodium salt | |
| US20090047354A1 (en) | process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate | |
| US20040167186A1 (en) | Use of certain crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide in treating epilepsy | |
| JPH07504892A (ja) | グリセロホスホコリンの製造のための結晶化方法 | |
| KR102445983B1 (ko) | 티아졸 유도체의 제조방법 | |
| BRPI0609739A2 (pt) | cristal, forma amorfa, método para produzir o cristal, composição farmacêutica, composição antagonista de receptor de quimiocina, e, droga preventiva ou droga terapêutica para doença | |
| CN103626710A (zh) | 2-(5-溴-4-(4-环丙基萘-1-基)-4h-1，2，4-三唑-3-基硫基)乙酸的共晶及其制备方法 | |
| EP0244113A1 (en) | B-lactam antibiotics | |
| JPWO2011036895A1 (ja) | マレイン酸塩およびその結晶 | |
| CN114164710B (zh) | 可实时无线监测水果新鲜度的多功能包装纸的制备方法 | |
| NO791772L (no) | Polyjodbenzen-roentgenkontrastmidler. | |
| CN100340550C (zh) | 咪酰胺的制备方法 | |
| Hurd et al. | Poly-2-amino-4-pentenoic acid and polytryptophan | |
| CN116548427A (zh) | 保护液以及存储颅骨瓣的方法 | |
| Donaldson et al. | The tin (II) halogen-substituted acetates | |
| DE944954C (de) | Verfahren zur Herstellung neuer Carbonsaeurehydrazide | |
| SHIMIZU et al. | The effects of radical scavengers and leukocyte-depleted blood on reperfusion injury of extirpated rabbit lung | |
| TW393486B (en) | Bicyclic beta-lactam/paraben complexes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220621 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241125 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241125 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241125 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251028 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251028 |